Tirzepatide

A dual GIP / GLP-1 receptor agonist and one of the most studied metabolic research compounds.

What it is

Tirzepatide is a dual agonist that activates both the GIP and GLP-1 receptors from a single molecule. By engaging two incretin pathways together it became a benchmark metabolic research compound and a frequent point of comparison for newer triple agonists.

What the research looks at

In research settings, tirzepatide is studied for metabolic regulation, weight management and glycemic control, with significant metabolic effects observed across research models. The dual GIP and GLP-1 activity is examined for how the two incretin pathways combine, which is why it is one of the most studied compounds in this area.

Supplied strictly for laboratory research use only, not for human or veterinary use.

At a glance

Preparing it

Reconstitute the lyophilized powder with bacteriostatic or sterile water, added slowly down the side of the vial and swirled, never shaken, until fully dissolved. The volume of water you add determines the concentration of the finished solution.

For the full procedure see reconstitution, and to work out concentration per unit see concentration & math.

Where to go next